SFSIG
EXAS

San Francisco Sentry Investment Group’s Exact Sciences EXAS Stock Holding History

San Francisco Sentry Investment Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$13K – 712
2021
Q1 		$13K Buy
+100
New +$13.7K 0.01% 521
2019
Q4 		– Sell
-6
Closed -$1K – 913
2019
Q3 		$1K Buy
+6
New +$684 ﹤0.01% 819
2018
Q4 		– Sell
-12
Closed -$1K – 1005
2018
Q3 		$1K Buy
+12
New +$783 ﹤0.01% 852

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

San Francisco Sentry Investment Group's EXAS Position: Q2 2021 in Review

San Francisco Sentry Investment Group sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 100 shares — an estimated $13K sold.

San Francisco Sentry Investment Group first reported a position in EXAS in Q3 2018 and held it in 3 quarters. The position peaked at $13K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • San Francisco Sentry Investment Group reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 100 Exact Sciences shares in Q2 2021, an estimated $13K.
  • San Francisco Sentry Investment Group first reported a position in Exact Sciences in Q3 2018 and held it in 3 quarters.
  • San Francisco Sentry Investment Group's Exact Sciences position peaked at $13K in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.